Botox Alternatives Compared
| Botox (onabotulinumtoxinA) | Oxybutynin | Myrbetriq (mirabegron) |
|
|---|
| Botox (onabotulinumtoxinA) | Oxybutynin | Myrbetriq (mirabegron) |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Botox is approved to treat many conditions, such as chronic migraine, involuntary muscle contractions or twitching, excessive sweating, increased saliva, and overactive bladder to name a few. Botox... View more |
Prescription and OTC
Oxybutynin helps to relieve symptoms of an overactive bladder and urinary incontinence but it may cause side effects such as a dry mouth and constipation. Prescribed for Overactive Bladder... View more |
Prescription only
Myrbetriq may be used to relieve symptoms of overactive bladder in adults such as urinary incontinence and urinary frequency. It may also be used to treat the symptoms of neurogenic detrusor... View more |
Related suggestions Urinary Frequency
Urinary Incontinence
Neurogenic Detrusor Overactivity
|
|||||||||||||||||||||||
| More about Botox (onabotulinumtoxinA) | More about Oxybutynin | More about Myrbetriq (mirabegron) | ||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Botox has an average rating of 5.7 out of 10 from a total of 470 ratings on Drugs.com. 47% of reviewers reported a positive effect, while 42% reported a negative effect. |
Oxybutynin has an average rating of 6.7 out of 10 from a total of 458 ratings on Drugs.com. 55% of reviewers reported a positive effect, while 23% reported a negative effect. |
Myrbetriq has an average rating of 4.9 out of 10 from a total of 276 ratings on Drugs.com. 35% of reviewers reported a positive effect, while 47% reported a negative effect. |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Side Effects | ||||||||||||||||||||||||||
| Generic Availability | ||||||||||||||||||||||||||
|
N/A |
Lower cost generic |
|||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Botox prices |
View all Oxybutynin prices |
View all Myrbetriq prices |
||||||||||||||||||||||||
| Dosage Forms Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
| Other onabotulinumtoxinA brands include: Botox Cosmetic | Ditropan XL, Gelnique, Oxytrol, Oxytrol for Women |
N/A |
||||||||||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
|
N/A |
2.3 hours |
50 hours |
||||||||||||||||||||||||
| CSA Schedule ** View glossary of terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 120 drugs are known to interact with Botox:
|
A total of 283 drugs are known to interact with Oxybutynin:
|
A total of 245 drugs are known to interact with Myrbetriq:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
December 09, 1991 |
July 16, 1975 |
June 28, 2012 |
||||||||||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.